Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE

NCT03871517 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT03871517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03871517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 3, 2019
Completion date
December 1, 2022
Enrollment
5,438 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, indobufen, ischemic stroke